Cargando…

Updated guidelines for chronic active Epstein–Barr virus disease

Chronic active Epstein–Barr virus disease (CAEBV), formerly named chronic active Epstein–Barr virus infection, is characterized by systemic inflammation and clonal proliferation of Epstein–Barr virus (EBV)-infected T or NK cells. As CAEBV is a potentially life-threatening illness, appropriate diagno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawada, Jun-ichi, Ito, Yoshinori, Ohshima, Koichi, Yamada, Masaki, Kataoka, Shinsuke, Muramatsu, Hideki, Sawada, Akihisa, Wada, Taizo, Imadome, Ken-Ichi, Arai, Ayako, Iwatsuki, Keiji, Ohga, Shouichi, Kimura, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615970/ https://www.ncbi.nlm.nih.gov/pubmed/37728704 http://dx.doi.org/10.1007/s12185-023-03660-5

Ejemplares similares

Systemic Epstein–Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants
por: Ishimura, Masataka, et al.
Publicado: (2019)

Composite Epstein-Barr Virus-associated T-lymphoblastic and Peripheral T-cell Lymphomas: A Clonal Study
por: Hosoi, Hiroki, et al.
Publicado: (2021)

Humanized Mouse Models of Epstein-Barr Virus Infection and Associated Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2013)

The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein–Barr Virus Infection
por: Ohashi, Ayaka, et al.
Publicado: (2022)

EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES: THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS
por: KIMURA, HIROSHI, et al.
Publicado: (2013)

STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target
por: Onozawa, Erika, et al.
Publicado: (2018)

Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis
por: Imai, Ayano, et al.
Publicado: (2017)

Epstein-Barr virus infection-induced inflammasome activation in human monocytes
por: Torii, Yuka, et al.
Publicado: (2017)

1792. Viral DNA Loads in Various Blood Components of Patients with EBV-Positive T/NK Cell Lymphoproliferative Diseases
por: Kawada, Jun-ichi, et al.
Publicado: (2019)

Antitumor effects of duvelisib on Epstein–Barr virus‐associated lymphoma cells
por: Kawada, Jun‐ichi, et al.
Publicado: (2018)

Epstein-Barr Virus-Associated γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic IL2RG Mutation
por: Tanita, Kay, et al.
Publicado: (2019)

Epstein-Barr Virus Induces Erosive Arthritis in Humanized Mice
por: Kuwana, Yoshikazu, et al.
Publicado: (2011)

Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2
por: Yang, Xi, et al.
Publicado: (2012)

Increased Granulopoiesis in the Bone Marrow following Epstein-Barr Virus Infection
por: Katahira, Yasuhiro, et al.
Publicado: (2019)

CD137 Expression Is Induced by Epstein-Barr Virus Infection through LMP1 in T or NK Cells and Mediates Survival Promoting Signals
por: Yoshimori, Mayumi, et al.
Publicado: (2014)

Recurrent Enteritis Associated with Epstein-Barr Virus-positive CD4(+) T-cell Lymphoproliferative Disorder after Autologous Stem Cell Transplantation
por: Kawaguchi, Shinichiro, et al.
Publicado: (2020)

Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines
por: Kotaki, Ryutaro, et al.
Publicado: (2020)

Chronic Active Epstein–Barr Virus Infection: The Elucidation of the Pathophysiology and the Development of Therapeutic Methods
por: Arai, Ayako
Publicado: (2021)

Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein–Barr virus-associated T cell and natural killer cell lymphoma
por: Siddiquey, Mohammed NA, et al.
Publicado: (2014)

Immunization with Epstein–Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge
por: Cui, Xinle, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders
por: Sawada, Akihisa, et al.
Publicado: (2018)

Human osteoclastogenesis in Epstein-Barr virus-induced erosive arthritis in humanized NOD/Shi-scid/IL-2Rγ(null) mice
por: Nagasawa, Yosuke, et al.
Publicado: (2021)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis and Guillain-Barre Syndrome in a 16-Month-Old Child
por: Matsui, Motohiro, et al.
Publicado: (2016)

Novel Mouse Xenograft Models Reveal a Critical Role of CD4(+) T Cells in the Proliferation of EBV-Infected T and NK Cells
por: Imadome, Ken-Ichi, et al.
Publicado: (2011)

Development of Epstein–Barr virus-associated lymphoproliferative disorder and hemophagocytic lymphohistiocytosis during long-term lenalidomide maintenance therapy in multiple myeloma
por: Yoshida, Mina, et al.
Publicado: (2022)

Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development
por: Arai, Ayako
Publicado: (2019)

Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus
por: Kim, Kyoung-Dong, et al.
Publicado: (2020)

Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells
por: Ando, Shotaro, et al.
Publicado: (2016)

Bilateral granulomatous panuveitis in two patients with T-cell type of chronic active Epstein-Barr virus infection
por: Takahashi, Hiroyuki, et al.
Publicado: (2019)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
por: Kataoka, Keisuke, et al.
Publicado: (2019)

Parvovirus B19-Infected Tubulointerstitial Nephritis in Hereditary Spherocytosis
por: Nishiyama, Kei, et al.
Publicado: (2020)

A20 (TNFAIP3) Deletion in Epstein-Barr Virus-Associated Lymphoproliferative Disorders/Lymphomas
por: Ando, Midori, et al.
Publicado: (2013)

Interferon-γ Produced by EBV-Positive Neoplastic NK-Cells Induces Differentiation into Macrophages and Procoagulant Activity of Monocytes, Which Leads to HLH
por: Yoshimori, Mayumi, et al.
Publicado: (2021)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_76bdss0suglh41kok0q33m1io0